Cargando…
Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin
Antiviral therapy using newer nucleos(t)ide analogues with lower resistance rates, such as entecavir or tenofovir, suppress hepatitis B virus (HBV) replication, improve liver function in patients with compensated or decompensated cirrhosis, and delay or obviate the need for liver transplantation in...
Autores principales: | Roche, Bruno, Roque-Afonso, Anne Marie, Nevens, Frederik, Samuel, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539198/ https://www.ncbi.nlm.nih.gov/pubmed/26038873 http://dx.doi.org/10.1097/TP.0000000000000777 |
Ejemplares similares
-
Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update
por: Dindoost, Payam, et al.
Publicado: (2012) -
Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance
por: Roche, Bruno, et al.
Publicado: (2015) -
Entecavir and Hepatitis B Immune Globulin in Patients Undergoing Liver Transplantation for Chronic Hepatitis B
por: Perrillo, Robert, et al.
Publicado: (2013) -
Role of lower dose hepatitis B immune globulin prophylaxis in liver transplantation: A single center perspective
por: Edwards, Diep, et al.
Publicado: (2023) -
Long-Term Effectiveness, Safety, and Patient-Reported Outcomes of Self-Administered Subcutaneous Hepatitis B Immunoglobulin in Liver Post-Transplant Hepatitis B Prophylaxis: A Prospective Non-Interventional Study
por: Roche, Bruno, et al.
Publicado: (2022)